[go: up one dir, main page]

Raugi et al., 1984 - Google Patents

Location and partial characterization of the heparin-binding fragment of platelet thrombospondin

Raugi et al., 1984

Document ID
3101813678153997523
Author
Raugi G
Mumby S
Ready C
Bornstein P
Publication year
Publication venue
Thrombosis research

External Links

Snippet

Purified platelet thrombospondin (TS) was subjected to proteolysis with a number of proteases including factors IX a X a, thrombin, elastase, trypsin, and chymotrypsin. All enzymes yielded fragments of TS which bound to heparin-Sepharose. Only chymotrypsin …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Raugi et al. Location and partial characterization of the heparin-binding fragment of platelet thrombospondin
Mumby et al. Interactions of thrombospondin with extracellular matrix proteins: selective binding to type V collagen.
Prater et al. The properdin-like type I repeats of human thrombospondin contain a cell attachment site.
Ben Nasr et al. Assembly of human contact phase proteins and release of bradykinin at the surface of curli‐expressing Escherichia coli
EP0573545B1 (en) Monoclonal antibodies against receptor-induced binding sites
US5792669A (en) Synthetic peptide and its uses
Jones et al. Fibronectin glycosylation modulates fibroblast adhesion and spreading.
Zamarron et al. A receptor-induced binding site in fibrinogen elicited by its interaction with platelet membrane glycoprotein IIb-IIIa
Akiyama et al. Function and receptor specificity of a minimal 20 kilodalton cell adhesive fragment of fibronectin
Fujimura et al. Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4, which inhibits both ristocetin-and botrocetin-induced vWF binding to platelet glycoprotein Ib
Kelm et al. Characterization of human osteoblast and megakaryocyte-derived osteonectin (SPARC)
JP2939557B2 (en) Peptides derivable from a 52/48 kDa polypeptide fragment of von Willebrand factor
van der Hoek et al. Binding of recombinant apolipoprotein (a) to extracellular matrix proteins.
Tandon et al. Interaction of human platelets with laminin and identification of the 67 kDa laminin receptor on platelets
Kobayashi et al. Inhibition of tumor cell invasion through matrigel by a peptide derived from the domain II region in urinary trypsin inhibition
Garcia-Pardo et al. Fibronectin receptors of mononuclear phagocytes: binding characteristics and biochemical isolation
Bennett The Platelet—Fibrinogen Interaction
Pidard et al. Neutrophil proteinase cathepsin G is proteolytically active on the human platelet glycoprotein Ib-IX receptor: characterization of the cleavage sites within the glycoprotein Ib α subunit
Ruiz et al. Digestion of C1q collagen‐like domain with MMPs‐1,‐2,‐3, and‐9 further defines the sequence involved in the stimulation of neutrophil superoxide production
Gaffney et al. Monoclonal antibodies to crosslinked fibrin degradation products (XL‐FDP) I. CHARACTERIZATION AND PRELIMINARY EVALUATION IN PLASMA
Engvall et al. Affinity chromatography of collagen on collagen-binding fragments of fibronectin
Harvath et al. Laminin peptides stimulate human neutrophil motility.
Trezzini et al. Low-affinity interaction of fibrinogen carboxy-gamma terminus with human monocytes induces an oxidative burst and modulates effector functions
Chu et al. Chido and Rogers antigenic determinant on the fourth component of human complement.
Easter et al. Immunosuppression by a peptide from the gelatin binding domain of human fibronectin